Endocrinology Advisor Social Media Survey 2014
How Do Endocrinology Advisor Readers Use Social Media?
Overall, social media for personal use was more popular than for business purposes, but 42% reported using it for both.
Most Popular Social Media Service
Although respondents generally favored using social networks for personal purposes, LinkedIn, Google+ and Doximity were more likely to be used for business. However, Facebook, which dominated in overall use (80%), was used by less than one-third for business.
Endocrinology Advisor Readers' Facebook Usage Frequency
Facebook was the social media service users were most likely to use more than once per day (20%), followed by Google+ (13%). Approximately 6% or fewer of all respondents reported using Twitter, YouTube, Pinterest, Instagram, LinkedIn or Doximity multiple times per day.
Endocrinology Advisor Readers' Google+ Usage Frequency
Google+ was the fourth most popular social media service overall after Facebook, YouTube and LinkedIn, but ranked second behind Facebook in terms of frequency of use.
Endocrinology Advisor Readers' Twitter Usage Frequency
Those who reported using Twitter did so most commonly on a monthly basis.
Endocrinology Advisor Readers' YouTube Usage Frequency
For those who reported using YouTube, weekly and monthly usage was more common than daily.
Endocrinology Advisor Readers' Pinterest Usage Frequency
Among the 45% of respondents who reported using Pinterest, most said they use the service on a weekly to monthly basis.
Endocrinology Advisor Readers' Instagram Usage Frequency
Overall, only 22% of those surveyed said they use Instagram, but the majority of those who did use it on a weekly or monthly basis.
Endocrinology Advisor Readers' LinkedIn Usage Frequency
Of the approximately 63% who reported using LinkedIn, weekly and monthly use was most common.
Endocrinology Advisor Readers' Doximity Usage Frequency
The majority of those surveyed do not use Doximity, but among those who did, monthly usage was most common.
What Types of Info Do Endocrinology Advisor Readers Share Via Social Media?
About two-thirds of endocrinologists surveyed use social media to share clinical information and professional news, with most using LinkedIn, Google+ and Facebook for this purpose.
Do Endocrinology Readers Use Social Media to Access Info on Products & Services?
More than 80% of respondents use social media to access information about products and services.
Does Social Media Benefit Endocrinology Advisor Readers' Careers?
Slightly more than one-third of respondents said using social media has had some benefit for their career.
Do Endocrinology Advisor Readers Think They Will Use Social Media More in 2015?
While more than half of respondents think their social media usage will increase in 2015, nearly one-third still remain unsure.
How do endocrinologists and diabetes educators use social media?
Do you suffer from fear of missing out — also known as FOMO — wondering if other health care providers are getting more out of social media websites than you? Could you get a better job if you networked on LinkedIn? Attract more patients by promoting your practice on Facebook? Be the first person to know about drug recalls that affect your patients from Twitter?
Endocrinology Advisor’s Social Media Survey attempts to answer those questions. Overall, 119 health care providers responded to our survey in November 2014, answering questions about how they used eight well-known social media services: Facebook, Google+, Twitter, YouTube, Pinterest, Instagram, LinkedIn and Doximity.
The results are in: Respondents were more likely to use some form of social media primarily for personal use than for business purposes (46% vs. 12%) Less than half, however, reported using social media for both personal and business reasons (42%; composite use across all websites).
The slides here further break down our findings about what information health care providers specializing in endocrinology like to consume on social media websites, general attitudes about how this form of media affects clinicians’ careers and much more.
Not every participant answered every question. We have indicated total number of respondents for each area addressed. Numbers may not add up to 100% due to rounding.
This is the first installment of Pulse Point, our new crowdsourced feature that aims to bring you easy to absorb visual insights on the latest trends among your clinician peers.
Endocrinology Advisor Articles
- Efficacy and Safety of Alirocumab in Diabetes Mellitus
- Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Transgender Youth Not Willing to Delay Hormone Therapy for Fertility Preservation
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- Single Blood Sample Highly Predictive for Subsequent Diabetes Diagnosis
- Plasma Methylglyoxal Levels Associated With CVD, Mortality in Type 2 Diabetes
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- AMA: Federal Government Must Tackle Rising Insulin Prices
- Diabetes Medication Reconciliation May Reduce Risk of ED Visits